Race and ethnicity often not reported in trials of medications for mental health conditions
A new study led by the University of Southampton has found that the race and ethnicity of participants in clinical trials of medications for mental health and neurodevelopmental conditions often go unrecorded. In the first comprehensive quantitative review of its kind, an international team of researchers found that just four in ten clinical trials (39%) report the race or ethnicity of the participants involved.
Other Articles in this Edition
How Genes Influence the Timing of a Baby’s First Step
‘Dangerous nonsense’: AI-authored books about ADHD for sale on Amazon
The New York Times Moves the Goalposts on ADHD (Commentary)
Pathological Demand Avoidance 101 | Undivided Conversations
Race and ethnicity often not reported in trials of medications for mental health conditions
ADHD in formerly institutionalized children tied to slower physical and brain growth
Teens with mental health conditions use social media differently than their peers, study suggests
The Impact of Sleep Medications on Psychiatric Disorders
Medicaid Unwinding Linked to Disrupted Chronic Medication Therapy in Youth